Shenzhen Glory Medical Co.,Ltd.

Symbol: 002551.SZ

SHZ

3.25

CNY

Market price today

  • -16.6251

    P/E Ratio

  • 0.6657

    PEG Ratio

  • 2.75B

    MRK Cap

  • 0.00%

    DIV Yield

Shenzhen Glory Medical Co.,Ltd. (002551-SZ) Financial Statements

On the chart you can see the default numbers in dynamics for Shenzhen Glory Medical Co.,Ltd. (002551.SZ). Companys revenue shows the average of 1100.394 M which is 0.158 % gowth. The average gross profit for the whole period is 277.046 M which is 0.142 %. The average gross profit ratio is 0.291 %. The net income growth for the company last year performance is -0.546 % which equals 0.057 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Shenzhen Glory Medical Co.,Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.077. In the realm of current assets, 002551.SZ clocks in at 1822.663 in the reporting currency. A significant portion of these assets, precisely 818.199, is held in cash and short-term investments. This segment shows a change of -0.111% when juxtaposed with last year's data. The debt profile of the company shows a total long-term debt of 269.544 in the reporting currency. This figure signifies a year_over_year change of -0.125%. Shareholder value, as depicted by the total shareholder equity, is valued at 2614.169 in the reporting currency. The year over year change in this aspect is -0.052%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 611.007, with an inventory valuation of 371.55, and goodwill valued at 1.43, if any. The total intangible assets, if present, are valued at 280.36.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

3585.05818.2920.11088.9
1264.3
1062.7
460.3
763.9
523.9
385.9
558.1
650.3
890.6
879.8
84.7
63.2
46.2
44.2

balance-sheet.row.short-term-investments

1239.9327.9434.9292.5
121.1
295.4
15
-197.9
-143.3
0
-164.3
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

2874.55611653.9871.2
904.1
1005.4
1173
1135.4
1309
1059
701.1
514.8
396.6
217.2
138.7
124.3
127.5
95.3

balance-sheet.row.inventory

1558.23371.5416.8375.9
343.7
302.9
254.5
360.9
327
299.1
332.9
293.5
65.8
41.9
62.9
31.9
28.1
17.4

balance-sheet.row.other-current-assets

119.4121.937.457.4
99
111.7
133.6
159.5
188.3
316
72.6
18.8
-36.9
-13
-10.1
-21.4
-29.2
-27.5

balance-sheet.row.total-current-assets

8137.231822.72028.22393.4
2611.1
2482.7
2021.4
2419.6
2348.3
2060
1664.7
1477.4
1316.1
1125.9
276.1
198
172.6
129.4

balance-sheet.row.property-plant-equipment-net

2001.82488.8556637.6
785.1
987.8
921.3
773.1
470.1
390.7
319.8
341.1
141.9
135.3
164.4
177.4
107.6
67.5

balance-sheet.row.goodwill

27.571.412.468.6
68.6
149.4
149.4
156.5
153.2
153.2
4
4
0
0
0
0
0.7
0

balance-sheet.row.intangible-assets

1099.93280.4510275.6
217.2
233.6
235.2
236.5
241.7
163
151.4
61.1
11.9
12.1
12.4
12.7
13
13.2

balance-sheet.row.goodwill-and-intangible-assets

1127.5281.8522.4344.2
285.8
383
384.6
392.9
394.9
316.2
155.4
65.1
11.9
12.1
12.4
12.7
13.7
13.2

balance-sheet.row.long-term-investments

437.58-194.7-288.190.1
110.9
-278.3
6
226
804
0
172.3
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

458.6103.9137.493.1
86.1
76.6
53.2
42
39.5
31.1
26.8
15
4.4
2.8
2.6
2
2.1
0.5

balance-sheet.row.other-non-current-assets

4052.721429.31304.61414.8
1182.3
1068.2
718.1
456.8
1.5
160.4
17.5
120.6
49.1
52.3
33.1
12.9
22.2
0

balance-sheet.row.total-non-current-assets

8078.222109.12232.32579.8
2450.2
2237.3
2083.2
1890.8
1709.9
898.3
691.8
541.7
207.3
202.5
212.5
205
145.5
81.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

16215.463931.74260.54973.2
5061.3
4720
4104.6
4310.4
4058.2
2958.3
2356.5
2019.2
1523.4
1328.4
488.6
403
318.1
210.7

balance-sheet.row.account-payables

1345.24381.9380447.1
466.9
641.3
697.9
890
892.7
592.3
459.5
339.5
126
42.2
41.7
32.4
23.4
12.4

balance-sheet.row.short-term-debt

146.1521.141.561.1
178.7
108.8
150.5
177.4
213.7
249.5
85.5
71.2
6.2
6.9
22.6
2.3
7.6
12.6

balance-sheet.row.tax-payables

296.1273.881.297.8
80.9
97.8
129.5
150.3
107.2
97.1
66.1
40.2
27.5
15.3
10.3
7.7
6.3
5.4

balance-sheet.row.long-term-debt-total

1106.62269.5290.6331.1
301.2
829
35.6
43
84.6
61
32.5
5.5
0
0
16.1
41.1
36.9
39.2

Deferred Revenue Non Current

324.5180.484.375
76.3
72.5
73.2
80.7
84.4
86.9
25.7
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0.67---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

275.8424.2237.17.5
5.1
64.5
238.2
71.7
178.3
105.4
130
87.9
87.5
44.6
93.5
77.8
52
31.8

balance-sheet.row.total-non-current-liabilities

1443.15354.2379417.4
377.4
901.8
110.9
129.3
337.1
171.3
82.3
42.3
25
21
35.7
46.9
43.1
44.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

4829.3311841261.21526.8
1415.9
1903.9
1327
1637.2
1887.3
1376.9
899.6
684.2
303.8
147.8
212.6
173.8
145.9
127.7

balance-sheet.row.preferred-stock

126.6459.565.20
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

3379.16844.8844.8844.7
820.3
706
705.9
706
444.1
435.5
362.7
276.8
184.5
123
61.5
61.5
39.5
31.9

balance-sheet.row.retained-earnings

2055.96429.8578.7829.7
772.1
665.3
669.3
621.3
496.7
382.7
305.7
237.2
203.8
173
147.9
103.5
67
44.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

2544.16-59.5-65.242.5
68.7
83.7
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

2671.321339.61333.61403.8
1320.4
881.6
945.5
924.1
823.4
612.1
695.5
736.4
825.2
883.8
65.9
63.9
63.5
5.5

balance-sheet.row.total-stockholders-equity

10777.252614.22757.13120.7
2981.3
2336.6
2320.7
2251.4
1764.2
1430.4
1364
1250.4
1213.5
1179.7
275.3
228.9
170
81.8

balance-sheet.row.total-liabilities-and-stockholders-equity

16215.463931.74260.54973.2
5061.3
4720
4104.6
4310.4
4058.2
2958.3
2356.5
2019.2
1523.4
1328.4
488.6
403
318.1
210.7

balance-sheet.row.minority-interest

608.88133.6242.2325.7
664.1
479.5
456.9
421.8
406.8
151
92.8
84.6
6.2
0.9
0.7
0.3
2.2
1.2

balance-sheet.row.total-equity

11386.132747.82999.33446.4
3645.4
2816.1
2777.6
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

16215.46---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

1677.49133.1146.8382.6
232
17.1
21
28
660.7
8.1
8
7.8
0.1
0
0
0
0
0

balance-sheet.row.total-debt

1252.77290.6332.1392.2
479.9
937.9
186.2
220.3
298.3
310.6
117.9
76.7
6.2
6.9
38.7
43.3
44.5
51.8

balance-sheet.row.net-debt

-1092.38-199.7-153.2-404.2
-663.4
170.6
-274.1
-543.5
-225.6
-75.4
-440.1
-573.6
-884.4
-872.9
-46
-19.9
-1.7
7.5

Cash Flow Statement

The financial landscape of Shenzhen Glory Medical Co.,Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -1.624. The company recently extended its share capital by issuing 0, marking a difference of 0.006 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to -176847492.650 in the reporting currency. This is a shift of -0.686 from the previous year. In the same period, the company recorded 125, 11.72, and -88.82, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -163.95 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 61.68, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

-142.04-327.988369.9
76.4
134.7
189.2
136.3
143.5
111
77.5
59.6
44.3
46.8
39.5
24.6
22.1

cash-flows.row.depreciation-and-amortization

37.412576.755.1
39.6
32
30.4
29.6
27.5
24.1
13.4
11.8
11.5
10
3.7
3
1.9

cash-flows.row.deferred-income-tax

0-44.4-1.2-1.1
-25.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

044.41.21.1
25.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

37.9-90.457.930.6
-57.9
-226.7
-19.4
16.1
-50.4
-190.4
-201.9
-58.1
-117.9
-7
15.1
-35.3
0

cash-flows.row.account-receivables

29.17156.349.6116.2
183.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

8.73-55.9-38.6-41
-49.1
106.3
-34.7
-27.9
40.1
-40.4
-26.3
-23.9
21
-31.2
-3.8
-10.7
23.8

cash-flows.row.account-payables

0-146.448.1-43.5
-167
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-44.4-1.2-1.1
-25.1
-333
15.3
44.1
-90.5
-150
-175.6
-34.2
-138.9
24.2
18.9
-24.6
-23.8

cash-flows.row.other-non-cash-items

-7.05389.72041.9
81.7
102.2
35.2
99.3
97
41.3
26.4
18.4
5.6
1.3
-0.2
4
1.5

cash-flows.row.net-cash-provided-by-operating-activities

-160.91000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-48.06-57.3-430-254.2
-254.6
-357.3
-345
-141.8
-83.8
-77
-84.6
-12.8
-8.5
-15.4
-82.5
-39.3
-40.1

cash-flows.row.acquisitions-net

1.231.50.5-67.1
255
447.3
29.9
0
-114.1
-17.5
-41.5
0
0
0
0
-0.7
0

cash-flows.row.purchases-of-investments

-1064.1-865.4-1221-295.2
-817
-199
-685.2
-509.7
0
-37.7
0
-0.1
0
0
-4.2
0
0

cash-flows.row.sales-maturities-of-investments

1192.05732.61087.2473.3
541
237.9
777.5
127.9
6.5
17.5
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

84.2711.7-0.1-5.4
-254.6
-357.3
1.2
35
-256
-3.1
0
0
0.2
14.6
2.7
0
0

cash-flows.row.net-cash-used-for-investing-activites

83.61-176.8-563.4-148.6
-530.2
-228.3
-221.6
-488.6
-447.4
-117.9
-126.1
-12.9
-8.3
-0.9
-84
-39.9
-40.1

cash-flows.row.debt-repayment

-103.35-88.8-248.4-204.2
-358.5
-814.1
-1075.3
-1016.8
-626.2
-101.3
-31.6
-19.8
-31.8
-29.6
-23.4
-7.3
-2.3

cash-flows.row.common-stock-issued

0.19000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

-0.19000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-57.3-164-30.3-49.8
-74.2
-84.5
-35.2
-18.2
-50.1
-34.3
-42.8
-27.5
-16.9
-2.5
-3
-3.2
-2.3

cash-flows.row.other-financing-activites

48.0861.7287338.9
1084.6
787.1
1322.3
1354.2
719.5
131.9
30
23.1
876.7
26.3
41.3
54.5
47.4

cash-flows.row.net-cash-used-provided-by-financing-activities

-45.97-191.18.384.9
652
-111.4
211.8
319.2
43.2
-3.8
-44.3
-24.2
828
-5.8
14.8
44
42.8

cash-flows.row.effect-of-forex-changes-on-cash

-8.86.14.7-20.3
2
-0.1
-7
2.8
-1.2
-0.8
-1.6
-0.4
0
-0.2
0
0.1
0

cash-flows.row.net-change-in-cash

-162.25-265.4-307.7413.6
263.6
-297.6
218.6
114.8
-187.9
-136.5
-256.6
-5.6
763.2
44.2
-11.1
0.5
28.3

cash-flows.row.cash-at-end-of-period

2036.43387.2652.6960.4
546.8
283.2
580.8
362.2
247.4
435.3
571.8
828.4
834.1
70.9
26.8
37.8
37.3

cash-flows.row.cash-at-beginning-of-period

2198.68652.6960.4546.8
283.2
580.8
362.2
247.4
435.3
571.8
828.4
834.1
70.9
26.8
37.8
37.3
9

cash-flows.row.operating-cash-flow

-160.9196.5242.6497.5
139.9
42.2
235.4
281.4
217.6
-14.1
-84.6
31.7
-56.5
51
58.1
-3.7
25.6

cash-flows.row.capital-expenditure

-48.06-57.3-430-254.2
-254.6
-357.3
-345
-141.8
-83.8
-77
-84.6
-12.8
-8.5
-15.4
-82.5
-39.3
-40.1

cash-flows.row.free-cash-flow

-208.9739.2-187.4243.3
-114.7
-315.1
-109.6
139.6
133.8
-91.1
-169.2
19
-65.1
35.6
-24.3
-42.9
-14.5

Income Statement Row

Shenzhen Glory Medical Co.,Ltd.'s revenue saw a change of -0.065% compared with the previous period. The gross profit of 002551.SZ is reported to be 197.6. The company's operating expenses are 217.49, showing a change of -4.785% from the last year. The expenses for depreciation and amortization are 125, which is a -0.233% change from the last accounting period. Operating expenses are reported to be 217.49, which shows a -4.785% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -154.184% year-over-year growth. The operating income is -121.22, which shows a -154.184% change when compared to the previous year. The change in the net income is -0.546%. The net income for the last year was -148.89.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

1155.161192.91275.71790.3
2267.3
1530.8
1630.4
2006.5
1946
1666.3
1166.8
730.9
421.3
348.4
270
208.5
138.1
116.4

income-statement-row.row.cost-of-revenue

972.72995.31053.81427.4
1572.6
1201
1228.5
1533.7
1471.1
1229.6
836.5
508.4
260.8
243.1
162.7
122.3
79.5
70.7

income-statement-row.row.gross-profit

182.44197.6221.9362.9
694.7
329.8
402
472.7
475
436.7
330.3
222.5
160.6
105.3
107.3
86.2
58.5
45.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

40.19---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

35.16---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

18.79---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-7.17-6.4115.4100.6
121.4
59
30.1
-0.1
7.8
4.5
2.5
7.3
3.3
1.7
0.7
0.5
-0.2
1.3

income-statement-row.row.operating-expenses

198217.5228.4267.9
311.5
203.2
197.4
228.3
245.1
238.8
176.2
127.3
89.9
68.2
49.1
39.7
26.1
20.1

income-statement-row.row.cost-and-expenses

1170.721212.81282.31695.3
1884
1404.2
1425.9
1762
1716.2
1468.4
1012.7
635.7
350.7
311.4
211.8
162
105.6
90.8

income-statement-row.row.interest-income

11.448.76.95.2
8.7
7.7
5.5
7.3
7
8.8
17.5
21.7
17
18.4
1.5
0.2
0.2
0.1

income-statement-row.row.interest-expense

1.7424.47.2
17
12.1
11.4
12
19
14.2
10.2
6.4
2.9
0.5
2.3
2.2
0.5
0.5

income-statement-row.row.selling-and-marketing-expenses

18.79---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

9.44-6.4-385.2-37.7
-1.8
-70.2
-51.6
-19.2
-67.7
-25.6
-20.7
0.6
1.9
15
-0.4
0.7
-3.9
-0.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-7.17-6.4115.4100.6
121.4
59
30.1
-0.1
7.8
4.5
2.5
7.3
3.3
1.7
0.7
0.5
-0.2
1.3

income-statement-row.row.total-operating-expenses

9.44-6.4-385.2-37.7
-1.8
-70.2
-51.6
-19.2
-67.7
-25.6
-20.7
0.6
1.9
15
-0.4
0.7
-3.9
-0.8

income-statement-row.row.interest-expense

1.7424.47.2
17
12.1
11.4
12
19
14.2
10.2
6.4
2.9
0.5
2.3
2.2
0.5
0.5

income-statement-row.row.depreciation-and-amortization

141.7395.912576.7
67.9
39.6
32
30.4
29.6
27.5
24.1
13.4
11.8
11.5
10
3.7
3
1.9

income-statement-row.row.ebitda-caps

14.82---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-122.75-121.20.8126.7
370.3
141
122.8
225.4
154.4
167.8
131.3
88.6
69.2
50.3
57.1
46.7
28.8
23.4

income-statement-row.row.income-before-tax

-113.31-127.6-384.489.1
368.5
70.8
153
225.3
162.2
172.3
133.4
95.8
72.5
52
57.8
47.2
28.6
24.7

income-statement-row.row.income-tax-expense

36.633.2-56.51
-1.5
-5.6
18.2
36.1
25.8
28.9
22.4
18.3
12.9
7.7
11.1
7.7
4
2.6

income-statement-row.row.net-income

-142.04-148.9-327.988
369.9
59.8
97.7
175.2
114.2
119.1
102.2
73.8
58.3
44.2
46.4
39.9
24.1
22

Frequently Asked Question

What is Shenzhen Glory Medical Co.,Ltd. (002551.SZ) total assets?

Shenzhen Glory Medical Co.,Ltd. (002551.SZ) total assets is 3931719261.000.

What is enterprise annual revenue?

The annual revenue is 545763408.000.

What is firm profit margin?

Firm profit margin is 0.166.

What is company free cash flow?

The free cash flow is -0.299.

What is enterprise net profit margin?

The net profit margin is -0.125.

What is firm total revenue?

The total revenue is -0.102.

What is Shenzhen Glory Medical Co.,Ltd. (002551.SZ) net profit (net income)?

The net profit (net income) is -148889156.240.

What is firm total debt?

The total debt is 290603679.000.

What is operating expences number?

The operating expences are 217491767.000.

What is company cash figure?

Enretprise cash is 616750849.000.